|
ZNF202 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.196700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.703300E-03 |
| Normal-vs-Stage2 |
5.417600E-04 |
| Normal-vs-Stage3 |
4.04600000000199E-05 |
| Normal-vs-Stage4 |
7.62690000000177E-05 |
| Stage1-vs-Stage2 |
9.465900E-02 |
| Stage1-vs-Stage3 |
2.436000E-02 |
| Stage1-vs-Stage4 |
4.141900E-02 |
| Stage2-vs-Stage3 |
9.813200E-01 |
| Stage2-vs-Stage4 |
8.176600E-01 |
| Stage3-vs-Stage4 |
7.629200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.202000E-04 |
| Normal-vs-AfricanAmerican |
1.173610E-02 |
| Normal-vs-Asian |
2.411000E-01 |
| Caucasian-vs-AfricanAmerican |
8.856200E-01 |
| Caucasian-vs-Asian |
4.003800E-02 |
| AfricanAmerican-vs-Asian |
1.148360E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.826900E-04 |
| Normal-vs-Female |
6.360200E-04 |
| Male-vs-Female |
5.457400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.699500E-03 |
| Normal-vs-Age(41-60Yrs) |
6.966600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.809690E-04 |
| Normal-vs-Age(81-100Yrs) |
1.055780E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.937570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.836200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.612300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.043000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.148100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.111770E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.804000E-03 |
| Classical-VS-Follicular |
8.275100E-03 |
| Classical-VS-Other |
7.945400E-01 |
| Classical-VS-Normal |
8.499100E-03 |
| Tall-VS-Follicular |
7.770400E-01 |
| Tall-VS-Other |
5.437000E-01 |
| Tall-VS-Normal |
1.91148999999502E-05 |
| Follicular-VS-Other |
5.401800E-01 |
| Follicular-VS-Normal |
5.61860000000136E-05 |
| Other-VS-Normal |
2.158800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.47790000000348E-05 |
| Normal-vs-N1 |
1.125600E-02 |
| N0-vs-N1 |
5.451600E-01 |
|
|
